In a new strategic partnership with Salus Optima, IFF are developing a data driven personalized nutrition, health and wellness platform targeting metabolic health
Posted:
1 in 4 adults worldwide are affected by metabolic health issues such as obesity, pre-diabetes, high cholesterol, and pre-hypertension. IFF announced its plans for accelerated entry into the personalized nutrition sector through a strategic partnership with Salus Optima, a British-based, digitally-enabled personalized nutrition, health and wellness company. Read more here.
The French delegation at GIANT will showcase digital tools that tackle real-world #healthcare challenges.
On Tuesday, hear their pitches on the Champion of Innovation stage from 11.45am- 12.30pm, and on the #AI Show stage from 12.45-1pm to discover how these…
Congratulations!
Our friends - Armis has successfully closed a $200 million Series D #funding round, propelling their company valuation to an impressive $4.2 billion.
Read more here.